New Technologies for Imaging of Barrett's Esophagus

Herbert C. Wolfsen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

There have been many developments in endoscopy-based imaging for the detection of Barrett's syndrome, dysplasia, and neoplasia in patients with Barrett's esophagus. This article reviews the studies on and compares the efficacy of several important endoscopic imaging modalities. Some of these technologies have already achieved regulatory approval, commercial availability, and establishment of clinical utility and practical application. The future of imaging for Barrett's syndrome likely rests with the development of molecular targeting with dysplasiatargeted probes that have been conjugated to dyes or nanoparticles.

Original languageEnglish (US)
Pages (from-to)487-502
Number of pages16
JournalSurgical Oncology Clinics of North America
Volume18
Issue number3
DOIs
StatePublished - Jul 2009

Fingerprint

Barrett Esophagus
Technology
Nanoparticles
Endoscopy
Coloring Agents
Neoplasms

Keywords

  • Auto-fluorescence imaging
  • Chromoendoscopy
  • Confocal endomicroscopy
  • High resolution endoscopy
  • Narrow band imaging
  • Optical coherence tomography
  • Spectroscopy

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

New Technologies for Imaging of Barrett's Esophagus. / Wolfsen, Herbert C.

In: Surgical Oncology Clinics of North America, Vol. 18, No. 3, 07.2009, p. 487-502.

Research output: Contribution to journalArticle

Wolfsen, Herbert C. / New Technologies for Imaging of Barrett's Esophagus. In: Surgical Oncology Clinics of North America. 2009 ; Vol. 18, No. 3. pp. 487-502.
@article{d4dd6d3955d040448335294e81cfe7c9,
title = "New Technologies for Imaging of Barrett's Esophagus",
abstract = "There have been many developments in endoscopy-based imaging for the detection of Barrett's syndrome, dysplasia, and neoplasia in patients with Barrett's esophagus. This article reviews the studies on and compares the efficacy of several important endoscopic imaging modalities. Some of these technologies have already achieved regulatory approval, commercial availability, and establishment of clinical utility and practical application. The future of imaging for Barrett's syndrome likely rests with the development of molecular targeting with dysplasiatargeted probes that have been conjugated to dyes or nanoparticles.",
keywords = "Auto-fluorescence imaging, Chromoendoscopy, Confocal endomicroscopy, High resolution endoscopy, Narrow band imaging, Optical coherence tomography, Spectroscopy",
author = "Wolfsen, {Herbert C.}",
year = "2009",
month = "7",
doi = "10.1016/j.soc.2009.04.001",
language = "English (US)",
volume = "18",
pages = "487--502",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - New Technologies for Imaging of Barrett's Esophagus

AU - Wolfsen, Herbert C.

PY - 2009/7

Y1 - 2009/7

N2 - There have been many developments in endoscopy-based imaging for the detection of Barrett's syndrome, dysplasia, and neoplasia in patients with Barrett's esophagus. This article reviews the studies on and compares the efficacy of several important endoscopic imaging modalities. Some of these technologies have already achieved regulatory approval, commercial availability, and establishment of clinical utility and practical application. The future of imaging for Barrett's syndrome likely rests with the development of molecular targeting with dysplasiatargeted probes that have been conjugated to dyes or nanoparticles.

AB - There have been many developments in endoscopy-based imaging for the detection of Barrett's syndrome, dysplasia, and neoplasia in patients with Barrett's esophagus. This article reviews the studies on and compares the efficacy of several important endoscopic imaging modalities. Some of these technologies have already achieved regulatory approval, commercial availability, and establishment of clinical utility and practical application. The future of imaging for Barrett's syndrome likely rests with the development of molecular targeting with dysplasiatargeted probes that have been conjugated to dyes or nanoparticles.

KW - Auto-fluorescence imaging

KW - Chromoendoscopy

KW - Confocal endomicroscopy

KW - High resolution endoscopy

KW - Narrow band imaging

KW - Optical coherence tomography

KW - Spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=66149134449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149134449&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2009.04.001

DO - 10.1016/j.soc.2009.04.001

M3 - Article

C2 - 19500738

AN - SCOPUS:66149134449

VL - 18

SP - 487

EP - 502

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 3

ER -